Retatrutide RT20 20mg*10vials

Retatropeptide RT20 (20mg x 10 vials) is the top-tier, highly potent triple-target receptor agonist peptide in the Retatropeptide series. As the final version of the GLP-1/GIP/GCGR triple-target metabolic modulator, RT20 boasts a fully optimized molecular structure, ultra-high receptor binding activity, and maximized metabolic regulatory efficacy. Compared to the standard versions RT10 and RT15, ​​RT20 exhibits stronger biological activity, faster onset of action, and longer duration of action in vivo, specifically designed for demanding preclinical studies, high-dose gradient trials, and extreme metabolic mechanism studies.

Product Function and Research Value

Retatropeptide RT20 comprehensively activates GLP-1, GIP, and glucagon receptors, achieving comprehensive metabolic regulation. The dual GLP-1/GIP pathway significantly enhances insulin sensitivity, stabilizes blood glucose levels, inhibits overeating, and maintains a lasting feeling of satiety, thereby supporting in-depth research into diabetes metabolism and insulin resistance. Enhanced GCGR pathway significantly increases resting energy expenditure, accelerates visceral fat breakdown and white adipose tissue browning, and improves lipid metabolism disorders. With its superior triple pathway synergistic effect, RT20 is ideally suited for high-standard scientific research in areas such as severe obesity, long-term metabolic remodeling, metabolic liver disease, and high-dose efficacy validation, providing more precise, convincing, and impactful experimental data for cutting-edge metabolic pharmacology research.

Core Product Advantages

1. RT20's Comprehensive Potency Upgrade: As the most active version in the Retatropeptide series, RT20 possesses fully optimized molecular affinity, with metabolic regulation capabilities superior to RT10 and RT15, ​​providing more significant experimental phenotypes for high-threshold scientific research.

2. 20mg Ultra-High Concentration: The exclusive high-dose formula contains twice the amount of traditional 10mg products per vial, perfectly suited for long-term use, large-scale animal models, high-dose gradient control experiments, and batch sample testing, eliminating the need for frequent dilution and significantly improving experimental stability and efficiency. 3. Superior Anti-degradation and Long-lasting Effect: The optimized molecular anti-degradation structure ensures ultra-stable bioactivity in long-term in vitro and in vivo experiments, effectively reducing data deviations caused by peptide activity loss.

4. High-purity pharmaceutical-grade quality: Aseptic vacuum freeze-drying technology ensures complete preservation of peptide activity. Each batch undergoes rigorous HPLC purity analysis and comes with a complete Certificate of Analysis (COA), featuring ultra-low impurities, zero contamination risk, and excellent batch reproducibility.

5. High-quality bulk packaging: 10 vials per box, standardized packaging, ideal for long-term laboratory storage, cutting-edge drug development, university research projects, and large-scale wholesale purchases.

Retatrutide RT20 20mg*10 vials, a top-tier, ultra-high-efficiency triple receptor agonist peptide. Optimized for severe obesity, glucose and lipid metabolism, and advanced preclinical laboratory studies targeting GLP-1/GIP/GCGR. Highest activity, ultra-high concentration, stable performance, with complete COA certification, available for wholesale.